TDB Backs Autoscope AI Whole Slide Imaging System

02 Mar 2026 CW Team

Ayukriyam Innovations Pvt. Ltd. is a deep?tech spin?off from the Molecular Imaging and Diagnostics Lab in the Department of Biochemical Engineering and Biotechnology at the Indian Institute of Technology Delhi (IIT Delhi). The company is focused on microscopy systems integrated with AI to enable rapid and deployable diagnosis of infectious diseases, particularly in resource?constrained settings. The developers are pursuing standardised, scalable workflows suitable for wider clinical adoption.

The Autoscope platform is being developed as a whole slide imaging system combined with AI driven image analytics to offer high throughput and standardised diagnostic workflows. The system seeks to enhance diagnostic accuracy while reducing dependence on imported equipment through indigenous research and development. Field performance evaluations are planned to assess clinical utility and operational scalability across diverse healthcare settings.

The sanctioned assistance from TDB will support establishment of a dedicated manufacturing facility, production of multiple product batches, and comprehensive field evaluations to prepare the platform for commercialisation. TDB reiterated its mandate to provide financial assistance for commercialisation of indigenous technologies developed through institutional research linkages and the Government underlined continued commitment to innovation?led growth in healthcare. The Secretary of TDB indicated that indigenous development of integrated imaging and AI platforms is vital for strengthening healthcare infrastructure, and the promoters of Ayukriyam conveyed that the support would accelerate manufacturing readiness and field deployment.

The Technology Development Board (TDB) of the Department of Science and Technology (DST) has entered into an agreement with Ayukriyam Innovations Pvt. Ltd. to develop Autoscope, a fully automated whole slide imaging and artificial intelligence (AI) driven diagnostic system. The project is intended to promote deep?tech innovation and technological self?reliance in healthcare by translating laboratory research into marketable solutions. The assistance aims to reduce import dependence for high?end imaging systems and to support Aatmanirbhar Bharat objectives. Ayukriyam Innovations Pvt. Ltd. is a deep?tech spin?off from the Molecular Imaging and Diagnostics Lab in the Department of Biochemical Engineering and Biotechnology at the Indian Institute of Technology Delhi (IIT Delhi). The company is focused on microscopy systems integrated with AI to enable rapid and deployable diagnosis of infectious diseases, particularly in resource?constrained settings. The developers are pursuing standardised, scalable workflows suitable for wider clinical adoption. The Autoscope platform is being developed as a whole slide imaging system combined with AI driven image analytics to offer high throughput and standardised diagnostic workflows. The system seeks to enhance diagnostic accuracy while reducing dependence on imported equipment through indigenous research and development. Field performance evaluations are planned to assess clinical utility and operational scalability across diverse healthcare settings. The sanctioned assistance from TDB will support establishment of a dedicated manufacturing facility, production of multiple product batches, and comprehensive field evaluations to prepare the platform for commercialisation. TDB reiterated its mandate to provide financial assistance for commercialisation of indigenous technologies developed through institutional research linkages and the Government underlined continued commitment to innovation?led growth in healthcare. The Secretary of TDB indicated that indigenous development of integrated imaging and AI platforms is vital for strengthening healthcare infrastructure, and the promoters of Ayukriyam conveyed that the support would accelerate manufacturing readiness and field deployment.

Real Estate

07 Jul 2026

SNN Estates Expands North Bengaluru Housing Project

SNN Estates has announced an expansion of its SNN Estates Felicity residential project in North Bengaluru following strong buyer demand, with 75 per cent of the first-phase inventory sold within three days of launch.The developer will add 76 apartments in the new phase, taking the project's estimated revenue potential to around Rs 1,000 crore upon completion of Phase 2.Spread across 6.5 acres in Rachenahalli, near Manyata Tech Park, the project comprises 604 apartments in 1.5, 2, 2.5, 3 and 4 BHK configurations. The development includes a 50,000-sq-ft clubhouse with amenities such as sports co..

Infrastructure Urban

07 Jul 2026

SCG Drives ASEAN Industrial Transformation Strategy

SCG is strengthening its focus on ASEAN as a key growth region by advancing industrial transformation, enhancing competitiveness and building resilient regional value chains. Thammasak Sethaudom, President and Chief Executive Officer, SCG, highlighted the need for industries to continuously develop capabilities, strengthen resilience and deepen regional cooperation to achieve sustainable long-term growth.SCG views ASEAN as an important growth engine alongside China, supported by favourable demographics, trade connectivity and investment flows. With ASEAN’s GDP projected to grow by around 4.7..

Products

07 Jul 2026

EUROBOND Expands NABL Accreditation to 51 Testing Parameters

EUROBOND, the flagship brand of Euro Panel Products, has expanded the National Accreditation Board for Testing and Calibration Laboratories (NABL) accreditation of its in-house laboratory from 16 to 51 mechanical and chemical testing parameters, making it the only Indian aluminium composite panel (ACP) manufacturer with accreditation covering such an extensive testing scope.The expanded accreditation enables the company to independently test coils, coatings, cores, aluminium composite panels (ACP) and metal composite panels (MCP) in accordance with international standards, including IS, ASTM, ..